<SEC-DOCUMENT>0001178913-22-000959.txt : 20220307
<SEC-HEADER>0001178913-22-000959.hdr.sgml : 20220307
<ACCEPTANCE-DATETIME>20220307073431
ACCESSION NUMBER:		0001178913-22-000959
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20220307
FILED AS OF DATE:		20220307
DATE AS OF CHANGE:		20220307

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IM Cannabis Corp.
		CENTRAL INDEX KEY:			0001792030
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40065
		FILM NUMBER:		22716252

	BUSINESS ADDRESS:	
		STREET 1:		1 ADELAIDE STREET EAST, UNIT 801
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5C 2V9
		BUSINESS PHONE:		416-256-4202

	MAIL ADDRESS:	
		STREET 1:		1 ADELAIDE STREET EAST, UNIT 801
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5C 2V9
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2227425.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 14pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">UNITED STATES<br>
      SECURITIES AND
        EXCHANGE COMMISSION</font><br>
      Washington, D.C. 20549<br>
      <br>
      <font style="font-size: 14pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Form 6-K</font><br style="line-height: 1.25;">
      <br>
      <font style="font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</font><br>
      <font style="font-weight: bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">For the month of <font style="font-weight: bold;"><u>March 2022</u></font>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">Commission File Number: <font style="font-weight: bold;"><u>001-40065</u></font></div>
    <div style="text-align: center; line-height: 1.25;"><br>
      <u><font style="font-size: 16pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">IM Cannabis
          Corp.</font></u><br>
      (Exact Name of Registrant as Specified in Charter)<br style="line-height: 1.25;">
      <br>
      <font style="font-weight: bold;"><u>Kibbutz Glil Yam, Central District, Israel 4690500</u></font><br>
      (Address of principal executive offices)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;">Form 20-F <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160; Form 40-F &#9746;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Note</font>: Regulation S-T Rule
      101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Note</font>: Regulation S-T Rule
      101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is
      incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not
      required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURE</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
      signed on its behalf by the undersigned, thereunto duly authorized.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="zd3636d7c6a83403d8a9cfba9c4341f2d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="vertical-align: middle;" colspan="2">
            <div style="line-height: 1.25; font-weight: bold;">IM CANNABIS CORP.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="vertical-align: middle;" colspan="2">
            <div style="line-height: 1.25;">(Registrant)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 5%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;" rowspan="1">
            <div style="line-height: 1.25;">Date: March 7, 2022</div>
          </td>
          <td style="width: 5%; vertical-align: middle;">
            <div style="line-height: 1.25;">By:</div>
          </td>
          <td style="width: 45%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-style: italic;">/s/ Oren Shuster</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 5%; vertical-align: middle;">
            <div style="line-height: 1.25;">Name:</div>
          </td>
          <td style="width: 45%; vertical-align: middle;">
            <div style="line-height: 1.25;">Oren Shuster</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 5%; vertical-align: middle;">
            <div style="line-height: 1.25;">Title:</div>
          </td>
          <td style="width: 45%; vertical-align: middle;">
            <div style="line-height: 1.25;">Chief Executive Officer and Director</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>EXHIBIT INDEX</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zefa09520448b4cb2aac5423f8ae6bbc9" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 10%; vertical-align: middle; background-color: #EEEEEE;">
            <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">99.1</a></div>
          </td>
          <td style="width: 90%; vertical-align: middle; background-color: #EEEEEE;">
            <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">Form 7 - Monthly Progress
                Report dated March 7, 2022</a></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u> Exhibit 99.1</u><br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><br>
      FORM 7<br style="line-height: 1.25;">
      <br>
      <u>MONTHLY PROGRESS REPORT</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Name of Listed Issuer: IM Cannabis Corp. (the &#8220;Issuer&#8221; or &#8220;IMC&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Trading Symbol: IMCC</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Number of Outstanding Listed Securities as of 28/2/2022:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">68,430,088<font style="background-color: #F2F2F2;">&#160;</font>Common Shares</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Date: March 7, 2022</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Report on Business</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zee3b5cbbf5924fc9920ef099425f2a9a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Provide a general overview and discussion of the development of the Issuer&#8217;s business and operations over the previous month. Where the Issuer was inactive disclose
              this fact.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z746a7165220a4907934f4e123a28ba80" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">On February 2, 2022, the Israeli Patent Office approved the registration of the trademark &#8220;Roma&#8221; (the &#8220;Roma Trademark&#8221;) by IMC Holdings Ltd. (&#8220;IMC
              Holdings&#8221;), the Issuer&#8217;s wholly-owned Israeli subsidiary. Roma is IMC Holdings&#8217; leading cannabis strain in Israel. The Roma Trademark is valid until July 1, 2031.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze73f7a31c7884a2c97f4ceffe0a441c9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">On February 8, 2022, the Issuer announced that it engaged MZHCI, LLC, an MZ Group Company ("MZ") to lead the Issuer's strategic investor relations
              and financial communications program across all key markets. The investor relations agreement between the Issuer and MZ (the "MZ Agreement") commenced on February 1, 2022, for a term of three months until April 30, 2022, and will
              automatically renew for an indefinite period, subject to termination by either party upon 30 days prior written notice. Pursuant to the MZ Agreement, MZ Group will be paid a fee of USD$14,000 per month, plus applicable taxes. Subject to the
              terms of the MZ Agreement and if the MZ Agreement remains in effect as of August 1, 2022, the Issuer will issue to MZ 35,000 common shares at a price per share to be determined based on the market price of the Issuer's common shares on the
              Canadian Securities Exchange ("CSE") on the trading day prior to August 1, 2022, subject to applicable discounts permitted under CSE policies.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z59bedc49b0b64ec69a5c4ceaf2faa2b1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Provide a general overview and discussion of the activities of management.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-weight: bold;">Management of the
        Issuer (&#8220;Management&#8221;) is focused on continuing the Issuer&#8217;s growth in all three markets in which it currently operates: Israel, Germany and Canada. Following the successful completion of the acquisition of Trichome Financial Corp. (&#8220;Trichome&#8221;) and
        MYM</font>&#160;<font style="font-weight: bold;">Nutraceuticals Inc. (&#8220;MYM&#8221;), on March 18, 2021, and July
        9, 2021, respectively, Management is focused on integrating and managing its Canadian assets in Canada and maximizing company-wide revenue and margins. Management is also focused on identifying new strategic investments and growth opportunities in
        Israel and Europe, including, but not limited to, entering the distribution and retail segments in Israel, and securing additional supply, distribution and sale agreements in Germany through Adjupharm GmbH (&#8220;Adjupharm&#8221;) and in Israel through Focus
        Medical</font>&#160;<font style="font-weight: bold;">Herbs Ltd. (&#8220;Focus Medical&#8221;).</font></div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z98c0b1c82c514bad9b2c8c449ada12b5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Describe and provide details of any new products or services developed or offered. For resource companies, provide details of new drilling, exploration or production
              programs and acquisitions of any new properties and attach any mineral or oil and gas or other reports required under Ontario securities law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7b3dd4fcd83a4e768a72b4a94dc5a7b6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Describe and provide details of any products or services that were discontinued. For resource companies, provide details of any drilling, exploration or production
              programs that have been amended or abandoned.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1a4f0e2a7b1748db83f05fb87c6e5250" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Describe any new business relationships entered into between the Issuer, the Issuer&#8217;s affiliates or third parties including contracts to supply products or services,
              joint venture agreements and licensing agreements etc. State whether the relationship is with a Related Person of the Issuer and provide details of the relationship.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za3cef192931544d3a348492d891fac7e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div><font style="font-weight: bold;">Please see section 1 above regarding the</font>&#160;<font style="font-weight: bold;">MZ Agreement. MZ is not a Related Person to the Issuer.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5cf3f76e561b4d8c916e480edc4856df" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">On February 1, 2022, the Issuer retained newswire services from PR Newswire Europe Ltd (&#8220;PR Newswire&#8221;) and Zadok-Keinan Ltd. (&#8220;ZK&#8221;) according to
              which PR Newswire and ZK will provide the Issuer newswire services in Canada and U.S., respectively. PR Newswire and ZK are not Related Persons to the Issuer.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5ba668cf61134e928be19ac97a7faaaf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">6.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Describe the expiry or termination of any contracts or agreements between the Issuer, the Issuer&#8217;s affiliates or third parties or cancellation of any financing
              arrangements that have been previously announced.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb4f0c8284f0b4fe7898309619c7112d4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">The Issuer terminated the agreement that was signed on November 13, 2019, with INFOR Financial Inc. ("INFOR") for capital markets support services.
              The termination is effective as of February 27, 2022.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1e353efd69ed488295765e0597126a9e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">The Issuer terminated the agreement that was signed on January 28, 2021 with Kanan Corbin Schupak &amp; Aronow, Inc. d/b/a KCSA Strategic
              Communications (&#8220;KCSA&#8221;) for investor relations and public relations services. The termination is effective as of February 20, 2022.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd8fb4cbd91784baf944b513e294dbb3d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">7.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Describe any acquisitions by the Issuer or dispositions of the Issuer&#8217;s assets that occurred during the preceding month. Provide details of the nature of the assets
              acquired or disposed of and provide details of the consideration paid or payable together with a schedule of payments if applicable, and of any valuation. State how the consideration was determined and whether the acquisition was from or the
              disposition was to a Related Person of the Issuer and provide details of the relationship.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4af23d47450d4b71a7927e537e5253f4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Describe the acquisition of new customers or loss of customers.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5abca86dd4df4f529cab4df273c1cb9e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Describe any new developments or effects on intangible products such as brand names, circulation lists, copyrights, franchises, licenses, patents, software,
              subscription lists and trade-marks.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z09f68ee02f20437aa3f0ca9c69a0cb53" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">In February 2022, the Issuer launched its popular Canadian brand, WAGNERS, in the Israeli medical cannabis market.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf18ad21382b245a3abda34298cf4a434" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">Please see section 1 above regarding the registration of the Roma Trademark.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zcbaa8912741b410a8da42518d1d469e5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Report on any employee hirings, terminations or lay-offs with details of anticipated length of lay-offs.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">In February 2022, the issuer hired thirteen employees and eighteen resignations or terminations of
      employees occurred.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zc42435df7abc4700a045bda035bd22ed" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">11.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Report on any labour disputes and resolutions of those disputes if applicable.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf5225d9a1f93457c812854744679b113" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">12.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Describe and provide details of legal proceedings to which the Issuer became a party, including the name of the court or agency, the date instituted, the principal
              parties to the proceedings, the nature of the claim, the amount claimed, if any, if the proceedings are being contested, and the present status of the proceedings.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On November 19, 2021, Adjupharm filed a Statement of Claim (the &#8220;Claim&#8221;) to the District Court of
      Stuttgart (the &#8220;Court&#8221;) against Stroakmont &amp; Atton Trading GmbH (&#8220;Stroakmont &amp; Atton&#8221;), its shareholders and managing directors regarding a debt owed by Stroakmont &amp; Atton to Adjupharm in an amount of approximately &#8364;947,563 for COVID-19
      test kits purchased by Stroakmont &amp; Atton from Adjupharm in May 2021. The Claim was accepted on December 2, 2021 by the Court. In January 2022, Stroakmont &amp; Atton filed its Statement of Defence to the Court. In February 2022, Adjupharm
      received a one-month extension to March 22, 2022, to file its response to Stroakmont &amp; Atton&#8217;s Statement of Defence. The court hearing is scheduled for May 27, 2022.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zbfb23ca6cd7f43a3b11c782b09853ef1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">13.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Provide details of any indebtedness incurred or repaid by the Issuer together with the terms of such indebtedness.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7b0e72b946e44f02b378bcb77a1d6b06" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">14.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Provide details of any securities issued and options or warrants granted.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="2" border="0" id="z0e4675ebec8b496fb48c1246ecfbf97c" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 27.18%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Security</div>
          </td>
          <td style="width: 17.19%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Number Issued</div>
          </td>
          <td style="width: 31.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Details of Issuance</div>
          </td>
          <td style="width: 23.65%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Use of Proceeds<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 27.18%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Common Shares</div>
            <div style="line-height: 1.25; text-align: center;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 17.19%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;208,312</div>
          </td>
          <td style="width: 31.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Exercise of stock options</div>
            <div style="line-height: 1.25; text-align: center;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 23.65%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;$333,299.20 to be used for working capital.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">State aggregate proceeds and intended allocation of proceeds.</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zc53d3314a00e4f4ebf5e2da721d699c0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">15.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Provide details of any loans to or by Related Persons.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9ae9ec4480a04d508ead8019576adcbe" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">16.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Provide details of any changes in directors, officers or committee members.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3abd80de69774b81b9248db451631d6e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">17.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Discuss any trends which are likely to impact the Issuer including trends in the Issuer&#8217;s market(s) or political/regulatory trends.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">The current global uncertainty with respect to the spread of COVID-19, the rapidly evolving nature
      of the pandemic and local and international developments related thereto and its effect on the broader global economy and capital markets may impact the Issuer&#8217;s business in the coming months.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">The Issuer has taken proactive measures to protect the health and safety of its employees in order
      to continue delivering high quality medical cannabis products to its patients and to maintain its financial health. The Issuer has postponed planned investments in certain jurisdictions until global economic risks subside, but it continues to focus
      on its acquisition strategy in Canada and Europe. The Issuer also continues to develop the IMC brand by increasing physician awareness and engagement to drive sales of IMC-branded medical cannabis products in Germany and by seeking new supply and
      sales agreements in Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">While the precise impact of the COVID-19 outbreak on the Issuer remains unknown, the rapid spread
      of COVID-19 and declaration of the outbreak as a global pandemic have resulted in travel advisories and restrictions, certain restrictions on business operations, social distancing precautions and restrictions on group gatherings which could have
      negative impact on businesses around the world, including the cannabis markets in which the Issuer and its subsidiaries and related companies operate. Such implications may also affect Trichome&#8217;s debtors, including their respective abilities to repay
      their obligations. The spread of COVID-19 may also have a material adverse effect on global economic activity and could result in volatility and disruption to global supply chains and the financial and capital markets. These disruptions could cause
      interruptions in supplies and other services from third parties upon which the Issuer relies; decrease demand for products; and cause staff shortages, reduced customer traffic, and increased government regulation, all of which may materially and
      negatively impact the business, financial condition and results of operations of the Issuer, its subsidiaries and Focus Medical.</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9747ff57eaa24f54b7e831225f37a2f5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution of the board of directors of the Issuer to sign this
              Certificate of Compliance.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9c2eb863479f4250a1307f07f5c0a6b9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>As of the date hereof there were no material information concerning the Issuer which has not been publicly disclosed.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4e634388f08e44e6ae1ceb2b8de067a2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The undersigned hereby certifies to the Exchange that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in
              National Instrument 14-101) and all Exchange Requirements (as defined in CNSX Policy 1).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z44d5b78a3611477ab382a9faac9a1ed7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>All of the information in this Form 7 Monthly Progress Report is true.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Dated: March 7, 2022</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
    <div style="text-align: justify; line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z45a0e301a6db447f9cab0a78c70f4395">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50.00%;">
              <div>
                <div><u>Oren Shuster</u></div>
                <div>Name of Director or Senior Officer</div>
                <div> <br>
                </div>
                <div><u> &#8220;Oren Shuster&#8221;</u><br>
                  Signature</div>
                <div> <br>
                </div>
                <div><u>Chief Executive Officer</u><br>
                  Official Capacity </div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="2" border="0" id="z40dfe324a4774cad9c7105a3354645dd" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 45.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic; font-weight: bold;">Issuer Details</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Name of Issuer</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">IM Cannabis Corp.</div>
          </td>
          <td style="width: 23.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">For Month End</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">February 2022</div>
          </td>
          <td style="width: 30.26%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Date of Report</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">YY/MM/D</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2022/03/07</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);" colspan="3">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Issuer Address</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">550 Burrard Street, Suite 2300, Bentall 5</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">City/Province/Postal Code</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Vancouver, BC V6C 2B5</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 23.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Issuer Fax No.</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(&#160; &#160;&#160; )</div>
          </td>
          <td style="width: 30.26%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Issuer Telephone No.</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">+972 546687515</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Contact Name</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yael Harrosh</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 23.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Contact Position</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Global Chief Legal and Operations Officer</div>
          </td>
          <td style="width: 30.26%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Contact Telephone No.</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">+972 546687515</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Contact Email Address</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>yael.h@imcannabis.com</u></div>
          </td>
          <td style="width: 54.19%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Web Site Address</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>http://www.imcannabis.com/</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
